Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB-WT) Equity Ratio (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Equity Ratio for 3 consecutive years, with 0.51 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 40.09% to 0.51 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.51 through Dec 2025, down 40.09% year-over-year, with the annual reading at 0.51 for FY2025, 40.09% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.51 at Nuvation Bio, down from 0.54 in the prior quarter.
  • The five-year high for Equity Ratio was 0.98 in Q1 2023, with the low at 0.43 in Q2 2024.
  • Average Equity Ratio over 3 years is 0.79, with a median of 0.87 recorded in 2024.
  • The sharpest move saw Equity Ratio crashed 55.6% in 2024, then skyrocketed 33.25% in 2025.
  • Over 3 years, Equity Ratio stood at 0.97 in 2023, then fell by 11.89% to 0.86 in 2024, then tumbled by 40.09% to 0.51 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.51, 0.54, and 0.58 for Q4 2025, Q3 2025, and Q2 2025 respectively.